ACADIA

Growth in the Parkinson's Disease Drug Market, Fueled by the Launch of Several New Therapies, Will be Offset by Generic Erosion of Key Agents

...en by the emergence of novel agents, most notably Merck Serono/EMD Serono/Newron Pharmaceuticals' safinamide, Solvay Pharmaceuticals' pardoprunox, and acadia Pharmaceuticals/Biovail Pharmaceuticals' pimavanserin, which will be used to treat niche Parkinson's disease populations. The report also finds ...

Partnership for Prescription Assistance Prepared to Help Louisiana Workers Hurt by Recession

...00 E. Main Street Ville Platte, LA Thursday, March 5 EVENT TIME: 9:00 a.m. - 10:00 a.m. ADDRESS: acadia Parish Health Unit 530 West Mill Street Crowley, LA EVENT TIME: 2:00 p.m. - 3:00 p.m. ...

In Face of Continuing Katrina and Rita Needs Red Cross Adds Resources to Gulf Coast

...ently live within one of the following hardest hit parishes and counties of southern Louisiana and south Mississippi. Those areas are: Louisiana acadia Parish, Allen Parish, Ascension Parish, Assumption Parish, Beauregard Parish, Calcasieu Parish, Cameron Parish, East Baton Rouge Parish, East Felician...

Exercising judgment: The psychology of fitness

...to help them stay motivated. But this valuable exercise tool can also have unintended consequences. Christopher Shields, a psychology professor at acadia University in Canada, looked at people in group exercise classes and found that those with high proxy-efficacy (i.e. those who relied heavily on someo...

ACADIA in Medical Technology

Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System

...ing Spine Arthroplasty Society (SAS) Meeting in London, England from April 27th-May 1st. Dr. Dryer will be presenting on the lumbar kinematics of the acadia Facet Replacement System on Thursday, April 30th at SAS. *Note: ACADIA(TM) is an investigational device in the United States. It is limited by Un...

Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research

...meros Corporation Development of ER-beta Agonists for the Treatment of Parkinson's Disease Roger Olsson, Ph.D., and Krista McFarland, Ph.D., acadia Pharmaceuticals, Inc. Multiphosphatase Inhibitors as Therapeutics for Parkinson's Disease Arnon Rosenthal, Ph.D., and Franz F. Hefti, Ph.D.,...

Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540

... Compound) in Human Subjects with Hypertension" -- Friday, May 16, 2008, 5:38 - 5:55 p.m. CDT (6:38 - 6:55 p.m. EDT) -- New Orleans Marriott, acadia Ballroom, 3rd Floor Poster presentation: -- "PS433540 a Novel Dual Acting Receptor Antagonist Dose Dependently Increases Plasma Renin Activity...

Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline

...ry of phase changes: The Five Most Promising Drugs Entering Phase III Trials - trazodone, (Depression), Labopharm - pimavanserin, (Schizophrenia), acadia Pharmaceuticals - salmon calcitonin, (Osteoporosis/Paget's disease), Novartis/Nordic Bioscience - Generx(TM), (Coronary artery disease), Cardium ...

Acadia Announces Positive Results From ACP-103 Phase II Schizophrenia Co-Therapy Trial

... SAN DIEGO--(BUSINESS WIRE)--Mar 19, 2007 - acadia Pharmaceuticals Inc. (Nasdaq:ACAD) today announced...rapy." Conference Call and Webcast Information acadia will host a conference call and webcast with slide...ewer side effects relative to existing treatments. acadia also is developing ACP-103 for the treatment of Pa...

ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research

... SAN DIEGO--(BUSINESS WIRE)--Mar 29, 2007 - acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmace...CP-104) with other Atypical Antipsychotic Agents," acadia researchers describe experiments that used cell ba...-103 to existing schizophrenia treatment regimens, acadia believes the optimal combination of 5-HT2A inverse...

ACADIA in Biological News

September Geology and GSA Today media highlights

...mixing in these environments. Physical and chemical evidence of the 1850 Ma Sudbury impact event in the Baraga Group, Michigan Peir K. Pufahl, acadia University, Earth and Environmental Science, Wolfville, Nova Scotia B4P 2R6, Canada; et al. Pages 827-830. A catastrophic extraterrestrial impact 1...

ACADIA in Biological Technology

Clinical Research Study Focuses on Little Known Behavioral Changes Related to Parkinson's Disease

...ude hallucinations, illusions and delusions. acadia Pharmaceuticals, a biopharmaceutical company headq... its continuing work in Parkinson's research. acadia Pharmaceuticals is now evaluating an investigation...survey conducted by MediciGlobal, a firm assisting acadia Pharmaceuticals in finding Parkinson's patients wi...